Analytical Approach on Metlife Inc (NYSE:MET)

Analysts are weighing in on how Metlife Inc (NYSE:MET), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.1. The stock is rated as buy by 6 analysts, with 5 outperform and 6 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 16.00 analysts offering adjusted EPS forecast have a consensus estimate of $1.39 a share, which would compare with $1.56 in the same quarter last year. They have a high estimate of $1.46 and a low estimate of $1.32. Revenue for the period is expected to total nearly $17.33B from $17.36B the year-ago period.

For the full year, 18.00 Wall Street analysts forecast this company would deliver earnings of 5.45 per share, with a high estimate of $5.79 and a low estimate of $5.17. It had reported earnings per share of $4.86 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $68.65B versus 69.47B in the preceding year.

The analysts project the company to maintain annual growth of around 12.40% percent over the next five years as compared to an average growth rate of 9.32% percent expected for its competitors in the same industry.

Among the 14 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for MET is $51.00 but some analysts are projecting the price to go as high as $62.00. If the optimistic analysts are correct, that represents a 47 percent upside potential from the recent closing price of $42.22. Some sell-side analysts, particularly the bearish ones, have called for $44.00 price targets on shares of Metlife Inc (NYSE:MET).

In the last reported results, the company reported earnings of $1.56 per share, while analysts were calling for share earnings of $1.49. It was an earnings surprise of 4.70%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Analysts: Jabil Circuit, Incorporated (NYSE:JBL)

Analysts are weighing in on how Jabil Circuit, Inc. (NYSE:JBL), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.7. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 11.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.25 a share, which would compare with $0.53 in the same quarter last year. They have a high estimate of $0.28 and a low estimate of $0.20. Revenue for the period is expected to total nearly $4.27B from $4.68B the year-ago period.

For the full year, 11.00 Wall Street analysts forecast this company would deliver earnings of 1.83 per share, with a high estimate of $1.86 and a low estimate of $1.78. It had reported earnings per share of $2.07 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $18.19B versus 17.90B in the preceding year.

The analysts project the company to maintain annual growth of around 12.00% percent over the next five years as compared to an average growth rate of 7.24% percent expected for its competitors in the same industry.

Among the 10 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for JBL is $20.50 but some analysts are projecting the price to go as high as $24.00. If the optimistic analysts are correct, that represents a 28 percent upside potential from the recent closing price of $18.78. Some sell-side analysts, particularly the bearish ones, have called for $16.00 price targets on shares of Jabil Circuit, Inc. (NYSE:JBL).

In the last reported results, the company reported earnings of $0.53 per share, while analysts were calling for share earnings of $0.45. It was an earnings surprise of 17.80%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Jabil Circuit Inc., together with its subsidiaries, provides electronic manufacturing services and solutions worldwide. The company operates in two segments, Electronics Manufacturing Services and Diversified Manufacturing Services. It offers electronics design, production, and product management services to companies in the automotive, consumer lifestyles and wearable technologies, defense and aerospace, digital home, emerging growth, healthcare, industrial and energy, mobility, networking and telecommunications, packaging, point of sale, and printing and storage industries. The companys services include integrated design and engineering; component selection, sourcing, and procurement; automated assembly; design and implementation of product testing; parallel global production; enclosure services; systems assembly, direct order fulfillment, and configure to order; and injection molding, metal, plastics, precision machining, and automation services. Jabil Circuit Inc. was founded in 1966 and is headquartered in St. Petersburg, Florida.

Analyst’s Keeping an Eye on Southwest Airlines Co (NYSE:LUV)

Analysts are weighing in on how Southwest Airlines Co (NYSE:LUV), might perform in the near term. Wall Street analysts have a much favorable assessment of the stock, with a mean rating of 1.9. The stock is rated as buy by 6 analysts, with 6 outperform and 4 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 15.00 analysts offering adjusted EPS forecast have a consensus estimate of $1.23 a share, which would compare with $1.03 in the same quarter last year. They have a high estimate of $1.30 and a low estimate of $1.15. Revenue for the period is expected to total nearly $5.41B from $5.11B the year-ago period.

For the full year, 16.00 Wall Street analysts forecast this company would deliver earnings of 4.17 per share, with a high estimate of $4.41 and a low estimate of $3.80. It had reported earnings per share of $3.52 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $20.79B versus 19.65B in the preceding year.

The analysts project the company to maintain annual growth of around 18.99% percent over the next five years as compared to an average growth rate of 18.20% percent expected for its competitors in the same industry.

Among the 14 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for LUV is $55.25 but some analysts are projecting the price to go as high as $67.00. If the optimistic analysts are correct, that represents a 68 percent upside potential from the recent closing price of $39.78. Some sell-side analysts, particularly the bearish ones, have called for $47.00 price targets on shares of Southwest Airlines Co (NYSE:LUV).

In the last reported results, the company reported earnings of $1.03 per share, while analysts were calling for share earnings of $1.02. It was an earnings surprise of 1.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Southwest Airlines Co. operates passenger airlines that provide scheduled air transportation services in the United States and near-international markets. As of December 31, 2015, it operated 704 Boeing 737 aircraft. The company served 97 destinations in 40 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as 7 near-international countries, including Mexico, Jamaica, The Bahamas, Aruba, the Dominican Republic, Costa Rica, and Belize. It also sells frequent flyer points and related services to business partners participating in the Rapid Rewards frequent flyer program, including car rental agencies, hotels, restaurants, and retailers. The company was founded in 1967 and is headquartered in Dallas, Texas.

Analysts: U.S. Bancorp (NYSE:USB) Stock Could Go to 51.00

Analysts are weighing in on how U.S. Bancorp (NYSE:USB), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.6. The stock is rated as buy by 9 analysts, with 3 outperform and 20 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 30.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.81 a share, which would compare with $0.80 in the same quarter last year. They have a high estimate of $0.85 and a low estimate of $0.78. Revenue for the period is expected to total nearly $5.20B from $4.99B the year-ago period.

For the full year, 33.00 Wall Street analysts forecast this company would deliver earnings of 3.28 per share, with a high estimate of $3.40 and a low estimate of $3.12. It had reported earnings per share of $3.15 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $20.90B versus 20.09B in the preceding year.

The analysts project the company to maintain annual growth of around 4.87% percent over the next five years as compared to an average growth rate of 8.18% percent expected for its competitors in the same industry.

Among the 27 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for USB is $45.46 but some analysts are projecting the price to go as high as $51.00. If the optimistic analysts are correct, that represents a 24 percent upside potential from the recent closing price of $41.06. Some sell-side analysts, particularly the bearish ones, have called for $40.00 price targets on shares of U.S. Bancorp (NYSE:USB).

In the last reported results, the company reported earnings of $0.80 per share, while analysts were calling for share earnings of $0.80. It was an earnings surprise of 0.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

U.S. Bancorp, a financial services holding company, provides a range of financial services in the United States. It offers depository services, which include checking accounts, savings accounts, and time certificate contracts; and lending services, such as traditional credit products, as well as credit card services, leasing financing, import/export trade, asset-backed lending, agricultural finance, and other products. The company also provides ancillary services, including capital markets, treasury management, and receivable lock-box collection services to corporate customers; and a range of asset management and fiduciary services for individuals, estates, foundations, business corporations, and charitable organizations. In addition, it offers investment and insurance products to the companys customers principally within its markets, as well as fund administration services to a range of mutual and other funds. Further, the company provides corporate and purchasing card, and corporate trust services; and merchant processing services, as well as offers cash and investment management, ATM processing, mortgage banking, and brokerage and leasing services. It serves individuals, businesses, institutional organizations, governmental entities, and other financial institutions. The company offers its services through a network of 3,133 banking offices primarily in the Midwest and West regions of the United States; and a network of 4,936 ATMs, as well as through on-line services and over mobile devices. U.S. Bancorp was founded in 1863 and is headquartered in Minneapolis, Minnesota.

Analyst Activity: Medtronic PLC (NYSE:MDT)

Analysts are weighing in on how Medtronic PLC (NYSE:MDT), might perform in the near term. Wall Street analysts have a  assessment of the stock, with a mean rating of 2.0. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 24.00 analysts offering adjusted EPS forecast have a consensus estimate of $1.02 a share, which would compare with $1.02 in the same quarter last year. They have a high estimate of $1.08 and a low estimate of $0.99. Revenue for the period is expected to total nearly $7.20B from $7.27B the year-ago period.

For the full year, 25.00 Wall Street analysts forecast this company would deliver earnings of 4.66 per share, with a high estimate of $4.71 and a low estimate of $4.60. It had reported earnings per share of $4.37 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $29.96B versus 28.83B in the preceding year.

The analysts project the company to maintain annual growth of around 7.60% percent over the next five years as compared to an average growth rate of 12.90% percent expected for its competitors in the same industry.

Among the 22 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for MDT is $88.39 but some analysts are projecting the price to go as high as $98.00. If the optimistic analysts are correct, that represents a 16 percent upside potential from the recent closing price of $84.59. Some sell-side analysts, particularly the bearish ones, have called for $51.00 price targets on shares of Medtronic PLC (NYSE:MDT).

In the last reported results, the company reported earnings of $1.02 per share, while analysts were calling for share earnings of $1.01. It was an earnings surprise of 1.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The companys Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, and peripheral vascular intervention products. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery, such as ventilators, capnography, and other airway products; sensors; monitors; compression and dialysis products; enteral feeding; wound care; and medical surgical products comprising operating room supply products, electrodes, needles, syringes, and sharps disposals. The companys Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; systems that incorporate advanced energy surgical instruments; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Analyst’s Ratings on Liberty Global plc – Class A Ordinary Shares (NASDAQ:LBTYA)

Analysts are weighing in on how Liberty Global plc – Class A Ordinary Shares (NASDAQ:LBTYA)  , might perform in the near term. Wall Street analysts have a much favorable assessment of the stock, with a mean rating of 1.9. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 4.00 analysts offering adjusted EPS forecast have a consensus estimate of $-0.15 a share, which would compare with $-0.53 in the same quarter last year. They have a high estimate of $0.17 and a low estimate of $-0.81. Revenue for the period is expected to total nearly $4.58B from $4.57B the year-ago period.

For the full year, 9.00 Wall Street analysts forecast this company would deliver earnings of -0.11 per share, with a high estimate of $0.80 and a low estimate of $-1.07. It had reported earnings per share of $-0.19 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $18.85B versus 18.28B in the preceding year.

The analysts project the company to maintain annual growth of around -0.33% percent over the next five years as compared to an average growth rate of 15.16% percent expected for its competitors in the same industry.

Among the 15 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for LBTYA is $50.68 but some analysts are projecting the price to go as high as $60.00. If the optimistic analysts are correct, that represents a 71 percent upside potential from the recent closing price of $35.04. Some sell-side analysts, particularly the bearish ones, have called for $32.50 price targets on shares of Liberty Global plc – Class A Ordinary Shares (NASDAQ:LBTYA)  .

In the last reported results, the company reported earnings of $-0.53 per share, while analysts were calling for share earnings of $0.16. It was an earnings surprise of -431.20%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Liberty Global plc, together with its subsidiaries, provides video, broadband Internet, fixed-line telephony, and mobile services in Europe, Chile, and Puerto Rico. It offers various residential services, including video services comprising basic and premium programming, electronic programming guide, high definition (HD) channel, digital video recorder (DVR), and HD DVR services; and video-on-demand, set-top box, pay-per-view programming, and 3D programming services, as well as television applications that allow access to programming on laptops, smartphones, and tablets. The company provides entertainment, sports, movies, documentaries, lifestyles, news, adult, children, and ethnic and foreign channels. It also offers broadband Internet services, such as email, address book, and parental controls; security; and online storage solutions and Web spaces. In addition, the company provides telephony services consisting of multi-featured and circuit-switched fixed-line telephony services; and mobile services comprising voice, short message service, and Internet access. Further, it offers voice, broadband Internet, data, video, wireless, and cloud services to small or home offices, small businesses, and medium and large enterprises, as well as on a wholesale basis to other operators. The company distributes its broadband services through cable distribution systems; and video services through direct-to-home satellite and multichannel multipoint distribution systems. Liberty Global plc was founded in 2004 and is based in London, the United Kingdom.

Pre-Market Stocks Briefing: GlycoMimetics Inc(NASDAQ:GLYC), Elizabeth Arden, Inc.(NASDAQ:RDEN)

GlycoMimetics Inc(NASDAQ:GLYC) stock dropped -13.16% in today’s pre market session with the price of $6.40. Over the last one month and over the past three months, GlycoMimetics, Inc’s shares gained 16.06% and 23.04%, respectively. Furthermore, the stock has gained 28.85% since the start of this year. The company’s shares are trading 5.93    % above their 50-day moving average. Additionally, GlycoMimetics, Inc has an RSI of 46.30.

GlycoMimetics, Inc. (GLYC), a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, June 17, 2016 announced the pricing of its underwritten public offering of 3,300,000 shares of its common stock at a price to the public of $6.10 per share. The net proceeds from the offering to GlycoMimetics are expected to be $18.6 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by GlycoMimetics. The offering is expected to close on or about June 22, 2016, subject to customary closing conditions.

Jefferies LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. Stifel, Nicolaus & Company, Incorporated and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering. GlycoMimetics has granted to the underwriters a 30-day option to purchase up to 495,000 additional shares of common stock at the public offering price, less the underwriting discount.

GlycoMimetics intends to use the net proceeds of the offering to conduct planned clinical trials of GMI-1271, to fund the research and development of its preclinical pipeline, including drug discovery, and for working capital and other general corporate purposes.

Elizabeth Arden, Inc.(NASDAQ:RDEN) stock on Friday’s pre market session gained 48.01% at price of $13.78. Over the last one month and the previous three months, Elizabeth Arden Inc’s shares gained 4.61% and 31.31%, respectively. Additionally, the stock has dropped -5.96% since the beginning of 2016. The company’s shares are trading above their 50-day and 200-day moving averages by -0.40% and -1.41%, respectively.

Revlon, Inc. (REV) and Elizabeth Arden, Inc. (RDEN) June 17, 2016 announced that they have signed a definitive agreement under which Revlon will acquire all of the outstanding shares of Elizabeth Arden for $14.00 per share in cash, representing an enterprise value for Elizabeth Arden of approximately $870 million.

By bringing together two highly complementary, iconic brand portfolios, Revlon will benefit from greater scale, an expanded global footprint, and a significant presence across all major beauty channels and categories, including the addition of Elizabeth Arden’s growing prestige skin care, color cosmetics and fragrances. The combination will leverage Revlon’s scale across major vendors and manufacturing partners, improving distribution and procurement. Cost synergies of approximately $140 million are expected to be achieved through the elimination of duplicative activities, leveraging purchasing scale, and optimizing the manufacturing and distribution networks of the combined company. The companies anticipate that they will achieve additional growth opportunities in both sales channels and geographies.

Expanded Category Mix: Revlon’s strength and expertise in color cosmetics, hair care, men’s grooming, antiperspirants, deodorants and beauty tools will be complemented by the addition of Elizabeth Arden’s world-class portfolio of licensed prestige fragrances and the internationally recognized line of Elizabeth Arden-branded prestige skin care, color cosmetics and fragrance products, highly profitable categories that are key to future industry growth.

Channel Diversification: Elizabeth Arden’s strong global reach in prestige distribution and travel retail will complement Revlon’s strength in mass and salons, strongly positioning the combined company in all key beauty channels.

Broader Geographic Footprint: Revlon currently sells its products in approximately 130 countries. With Elizabeth Arden’s presence in important international growth regions, including Asia Pacific, the combined company will be better positioned to compete globally.

 

Pre-Market Stocks Roundup: Comtech Telecomm. Corp.(NASDAQ:CMTL), Lumber Liquidators Holdings Inc(NYSE:LL)

Comtech Telecomm. Corp.(NASDAQ:CMTL) stock dropped -12.04% in today’s pre market session with the price of $14.17. Over the last one month and over the past three months, Comtech Telecomm, Inc’s shares lost -27.98% and -31.98%, respectively. Furthermore, the stock has plummeted -17.42% since the start of this year. The company’s shares are trading -28.44% below their 50-day moving average. Additionally, Comtech Telecomm, Inc has an RSI of 12.88 and beta of 1.45.

Comtech Telecommunications Corp. June 16, 2016 announced the pricing of its public offering of 7,145,000 shares of its common stock at a public offering price of $14.00 per share for gross proceeds of approximately $100 million. Comtech expects to receive net proceeds, after deducting the underwriting discount, of approximately $95 million from the offering. All of the shares in the offering are being sold by Comtech. Comtech has granted the underwriters a 30-day option to purchase up to an additional 1,071,750 shares of common stock sold in the offering. The offering is scheduled to close on June 22, 2016, subject to customary closing conditions.

The Company intends to use the net proceeds of the common stock offering to repay borrowings under its Secured Credit Facility and for working capital and general corporate purposes.

The offering is being made through an underwriting group led by Citigroup and Jefferies LLC who are acting as joint book-running managers of the offering. BMO Capital Markets Corp. and Raymond James & Associates, Inc. are acting as additional book-running managers for the offering. Northland Securities, Inc., Ladenburg Thalmann & Co. Inc., Noble International Investments, Inc. and Santander Investment Securities Inc. are acting as co-managers.

Lumber Liquidators Holdings Inc(NYSE:LL) stock on Friday’s pre market session gained 12.40% at price of $14.87. Over the last one month and the previous three months, Lumber Liquidators Holdings Inc’s shares gained 14.15% and 16.77%, respectively. Additionally, the stock has lost -23.79% since the beginning of 2016. The company’s shares are trading above their 50-day and 200-day moving averages by -2.75% and -5.55%, respectively.

June 06, 2016Lumber Liquidators (LL), the largest specialty retailer of hardwood flooring in North America, has provided the Indianapolis Opera with more than 1,600 square feet of hardwood flooring to renovate their Recital Hall stage.

The only professional opera company in Indiana, the Indianapolis Opera has inspired generations with engaging educational, cultural and community activities. It plays a lead role in arts-focused community collaborations throughout the state, including free concerts, programs in senior living communities and events that help children explore music and art.

Lumber Liquidators donated and installed Hunter Red Oak Engineered Hardwood flooring as the new stage for the Indianapolis Opera’s Recital Hall. It was selected for its durability and style, which offers a harmonious blend of a classic honey color and strong oak graining.

“We very much appreciate the corporate leadership shown by Lumber Liquidators in the Indianapolis community,” said Kevin Patterson, general director of the Indianapolis Opera. “The donated wood flooring represents not only a welcome addition to our performance hall, their participation sends a strong and lasting signal that the arts are valued in our community.”

Lumber Liquidators’ support of the Indianapolis Opera was administered through its philanthropic program, Lay It Forward, which supports organizations that benefit generations to come. This principle also inspires the lasting quality and sustainability of Lumber Liquidators’ products.

Noteworthy Movers in Pre-Market: Innocoll Holdings PLC(NASDAQ:INNL), Transocean LTD(NYSE:RIG)

Innocoll Holdings PLC. (NASDAQ:INNL) stock dropped -4.23% in today’s pre market session with the price of $7.02. Over the last one month and over the past three months, Innocoll Holdings PLC shares lost -2.27% and -8.94%, respectively. Furthermore, the stock has plummeted -11.69% since the start of this year. The company’s shares are trading -16.41% below their 50-day moving average. Additionally, Innocoll Holdings has an RSI of 34.33.

Innocoll Holdings plc (INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting areas of significant unmet medical need, June 16, 2016 announced that it has priced an underwritten public offering of 5,725,000 ordinary shares at a price to the public of $7.00 per ordinary share, for aggregate gross proceeds to the Company of approximately $40.1 million.  All of the ordinary shares in the offering are being sold by Innocoll.  Certain of our officers and directors have agreed to purchase ordinary shares in the offering at the public offering price.  In addition, Innocoll has granted the underwriters of the offering a 30-day option to purchase up to an additional 858,750 ordinary shares in connection with the offering to cover over-allotments.  The offering is expected to close on June 22, 2016, subject to customary closing conditions.

Morgan Stanley is acting as lead book-running manager, Piper Jaffray & Co. is acting as joint book-running manager, Stifel is acting as lead manager, and FBR and Janney Montgomery Scott are acting as co-managers for the offering.

The Company expects to receive net proceeds from the offering, after deducting underwriting discounts and commissions and other expenses payable by it, of approximately $37.0 million.

Transocean LTD. (NYSE:RIG) stock on Friday’s pre market session gained 8.94% at price of $11.96. Over the last one month and the previous three months, Transocean shares gained 8.68% and ticked down -10.16%, respectively. Additionally, the stock has lost -15.02% since the beginning of 2016. The company’s shares are trading above their 50-day and 200-day moving averages by 4.23% and -11.12%, respectively.

Transocean Ltd. (RIG) May 4, 2016 reported net income attributable to controlling interest of $249 million, $0.68 per diluted share, for the three months ended March 31, 2016. First quarter 2016 results included net unfavorable items of $5 million, $0.01 per diluted share, as follows:

$4 million, $0.01 per diluted share, in restructuring costs associated with employee severance; and

$2 million related to the loss on impairment of the midwater floater Transocean John Shaw, which the company has identified for recycling.

These net unfavorable items were partially offset by:

$1 million in favorable discrete tax benefits and miscellaneous other items.

After consideration of these net unfavorable items, first quarter 2016 adjusted net income was $254 million, or $0.69 per diluted share.

For the three months ended March 31, 2015, the company reported a net loss attributable to controlling interest of $483 million, or $1.33 per diluted share. The first quarter of 2015 included net unfavorable items of $881 million, $2.43 per diluted share, associated with losses on the impairment of the deepwater floater asset group and other assets classified as held for sale. After consideration of these net unfavorable items, adjusted net income was $398 million, or $1.10 per diluted share.

Contract drilling revenues for the three months ended March 31, 2016, decreased $345 million sequentially to $1.11 billion due primarily to reduced activity associated with stacked and idle rigs, and rig disposals.

Other revenues decreased $165 million sequentially to $230 million. First quarter 2016 included $209 million in early contract termination fees ($133 million, net of expected quarterly contract drilling revenues for the cancelled rigs) primarily associated with the Discoverer Deep Seas and Deepwater Millennium.

Operating and maintenance expense decreased to $665 million, compared with $794 million in the prior quarter. The decrease was due largely to lower activity, cost savings related to the company`s operational and restructuring initiatives, and reduced stacking costs primarily associated with the company`s dynamically positioned floaters offset partially by the reactivation costs of the Henry Goodrich. The quarter also included deferred mobilization cost of $18 million on the GSF Development Driller I that was previously expected in the second quarter of 2016.

Premarket Runners: Orange SA (ADR) (NYSE:ORAN), Vascular Biogenics Ltd(NASDAQ:VBLT)

Orange SA (ADR)(NYSE:ORAN) stock dropped -2.89% in today’s pre market session with the price of $15.46. Over the last one month and over the past three months, Orange SA shares lost -3.37% and -8.70%, respectively. Furthermore, the stock has plummeted -1.45% since the start of this year. The company’s shares are trading -5.72% above their 50-day moving average. Additionally, Orange SA has an RSI of 40.29 and beta of 0.95.

Orange Business Services announced june 9, 2016 that it has integrated its acceleration service Enterprise Application Management (EAM) Riverbed into Business VPN Galerie to significantly improve the user experience for cloud users at remote sites. The service boosts the performance of all major cloud services in Business VPN Galerie over enterprise customers’ VPNs.

Enterprises moving from on-site applications to software as a service (SaaS) and Infrastructure as a Service (IaaS) models need their data to be secure and expect the same experience as if their data were stored locally. Cloud acceleration allows them to eliminate the frustration of a slow and unpredictable cloud application experience that can sometimes affect users in remote site.

Business VPN Galerie extends the Orange corporate VPN to the cloud via fully-secured gateways. It allows enterprises to access best-of-breed IaaS and SaaS cloud service providers, including Orange, while benefitting from the advantages of the Orange Business Services cloud-ready network – including end-to-end management and support, reliability, security and high performance.

EAM Riverbed is a fully-managed service from Orange Business Services that delivers application acceleration and WAN optimization. It can significantly improve application response times thereby improving the end user experience. EAM Riverbed also delivers traffic optimization using protocol optimization, caching and traffic compression, which can increase throughput by three times or more.

“Customers need to boost end-user application experience with faster response times to increase productivity at a global scale, enable business-critical migration projects and improve the corporate image. By integrating Riverbed’s best-of-breed technology in our secure and fully-managed solution we can deliver this promise,” said Pierre-Louis Biaggi, vice president connectivity business unit, Orange Business Services.

“Application performance and agility are key in today’s cloud computing world and we’re pleased to further extend the Orange and Riverbed strategic partnership to offer customers a compelling solution,” said Phil Harris, Chief Strategy Officer at Riverbed Technology.

 

Vascular Biogenics Ltd(NASDAQ:VBLT) stock on Friday’s pre market session gained 5.66% at price of $4.85. Over the last one month and the previous three months, Vascular Biogenics  shares gained 40.37% and 35.00%, respectively. Additionally, the stock has lost  12.74% since the beginning of 2016. The company’s shares are trading above their 50-day moving averages by 27.03%.

Vascular Biogenics Ltd. announced that on June 10, 2016, it closed its previously announced sale and issuance of approximately 4.36 million ordinary shares to institutional investors in the United States at a purchase price of $5.50 per share in a registered direct offering with gross proceeds of approximately $24 million.

Rodman & Renshaw, a unit of H.C. Wainwright & Co., acted as the exclusive placement agent for the registered direct offering.

The net proceeds to VBL Therapeutics from the offering were approximately $22.1 million, after subtracting placement agent fees and offering expenses payable by the Company.  VBL Therapeutics intends to use the net proceeds from the offering for the advancement of clinical programs, and for working capital and other general corporate purposes.

The ordinary shares were sold in the offering by VBL Therapeutics pursuant to a shelf registration statement on Form F-3 (No. 333-207250), including a base prospectus, previously filed with and declared effective by the Securities and Exchange Commission (the “SEC”). The final prospectus supplement related to the offering was filed with the SEC dated June 7, 2016 and is available on the SEC’s website located at www.sec.gov. Copies of the prospectus supplement and the accompanying prospectus relating to the securities may also be obtained by an email request to Rodman & Renshaw, a unit of H.C. Wainwright & Co., at placements@hcwco.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.  Any offering will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.